Plant glycans: Friend or foe in vaccine development?

Expert Review of Vaccines

Volumn 9, Issue 8, 2010, Pages 835-842

  Bosch, Dirk ^a,b   Schots, Arjen ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

C type lectin receptor; glycoengineering; glycosylation; N glycan; pattern recognition receptor; plant expression; subunit vaccine; Toll like receptor; vaccine

Indexed keywords

ANTIBODY; C TYPE LECTIN RECEPTOR; CARBOHYDRATE; GLYCAN; LECTIN RECEPTOR; PATTERN RECOGNITION RECEPTOR; SUBUNIT VACCINE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; GLYCOPROTEIN; RECOMBINANT VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARABIDOPSIS; BIOENGINEERING; ENDOCYTOSIS; GLYCOENGINEERING; GLYCOSYLATION; HUMAN; INNATE IMMUNITY; NICOTIANA BENTHAMIANA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC PLANT; VACCINE PRODUCTION; WILD TYPE; BIOSYNTHESIS; BIOTECHNOLOGY; GENETICS; IMMUNOLOGY; PHARMACEUTICS; PROCEDURES; PROTEIN PROCESSING;

BIOTECHNOLOGY; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; PLANTS, GENETICALLY MODIFIED; PROTEIN PROCESSING, POST-TRANSLATIONAL; TECHNOLOGY, PHARMACEUTICAL; VACCINES, SYNTHETIC;

EID: 77955262351     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.83     Document Type: Review

References (65)

1. Fenner F, Henderson DA, Arita I, JeZek Z, Ladnyi ID. Smallpox and its eradication. World Health Organization, Geneva, Switzerland (1988).
2. Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 89(24), 11745-11749 (1992).
3. Yusibov V, Rabindran S. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines 7(8), 1173-1183 (2008).
4. Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol. J. 8, 1-18 (2010).
5. Jin C, Altmann F, Strasser R et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 18(3), 235-241 (2008).
6. Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23(15), 1770-1778 (2005).
7. van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int. Arch. Allergy Immunol. 129(3), 189-197 (2002).
8. Fiedler K, Simons K. The role of N-glycans in the secretory pathway. Cell 81(3), 309-312 (1995).
9. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631-664 (1985).
10. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 126(5), 855-867 (2006).
11. Helenius J, Ng DT, Marolda CL, Walter P, Valvano MA, Aebi M. Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein. Nature 415(6870), 447-450 (2002).
12. Snider MD, Sultzman LA, Robbins PW. Transmembrane location of oligosaccharide- lipid synthesis in microsomal vesicles. Cell 21(2), 385-392 (1980).
13. Henquet M, Lehle L, Schreuder M et al. Identification of the gene encoding the a1,3-mannosyltransferase (ALG3) in Arabidopsis and characterization of downstream N-glycan processing. Plant Cell 20(6), 1652-1664 (2008).
14. Jin H, Yan Z, Nam KH, Li J. Allele-specific suppression of a defective brassinosteroid receptor reveals a physiological role of UGGT in ER quality control. Mol. Cell 26(6), 821-830 (2007).
15. Lederkremer GZ. Glycoprotein folding, quality control and ER-associated degradation. Curr. Opin. Struct. Biol. 19(5), 515-523 (2009).
16. Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Laine AC, Gomord V, Faye L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 38(1-2), 31-48 (1998).
17. Vitale A, Chrispeels MJ. Transient N-acetylglucosamine in the biosynthesis of phytohemagglutinin: attachment in the Golgi apparatus and removal in protein bodies. J. Cell Biol. 99(1 Pt 1), 133-140 (1984).
18. Fitchette-Laine A-C, Gomord V, Cabanes M et al. N-glycans harboring the Lewis A epitope are expressed at the surface of plant cells. Plant J. 12(6), 1411-1417 (1997).
19. Bakker H, Schijlen E, de Vries T et al. Plant members of the a1,3/4- fucosyltransferase gene family encode an a 1,4-fucosyltransferase, potentially involved in Lewis(A) biosynthesis, and two core a 1,3-fucosyltransferases. FEBS Lett. 507(3), 307-312 (2001).
20. Elbers IJ, Stoopen GM, Bakker H et al. Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves. Plant Physiol. 126(3), 1314-1322 (2001).
21. Sturm A, Van Kuik JA, Vliegenthart JF, Chrispeels MJ. Structure, position, and biosynthesis of the high mannose and the complex oligosaccharide side chains of the bean storage protein phaseolin. J. Biol. Chem. 262(28), 13392-13403 (1987).
22. Mari A. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int. Arch. Allergy Immunol. 129(4), 286-295 (2002).
23. Foetisch K, Westphal S, Lauer I et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. J. Allergy Clin. Immunol. 111(4), 889-896 (2003).
24. Bublin M, Radauer C, Wilson IB et al. Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. FASEB J. 17(12), 1697-1699 (2003).
25. van Ree R. Clinical importance of cross-reactivity in food allergy. Curr. Opin. Allergy Clin. Immunol. 4(3), 235-240 (2004).
26. Bardor M, Faveeuw C, Fitchette A-C et al. Immunoreactivity in mammals of two typical plant glyco-epitopes, core a1,3-fucose and core xylose. Glycobiology 13(6), 427-434 (2003).
27. Faye L, Chrispeels MJ. Common antigenic determinants in the glycoproteins of plants, molluscs and insects. Glycoconjugate J. 5(3), 245-256 (1988).
28. Chargelegue D, Vine ND, van Dolleweerd CJ, Drake PM, Ma JK. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res. 9(3), 187-194 (2000).
29. Ma JK, Hikmat BY, Wycoff K et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4(5), 601-606 (1998).
30. Mari A, Ooievaar-de Heer P, Scala E et al. Evaluation by double-blind placebo- controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy 63(7), 891-896 (2008).
31. Huether CM, Lienhart O, Baur A et al. Glyco-engineering of moss lacking plant-specific sugar residues. Plant Biol. (Stuttg.) 7(3), 292-299 (2005).
32. Schahs M, St rasser R, Stad lma nn J, Kunert R, Rademacher T, Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J. 5(5), 657-663 (2007).
33. Strasser R, Stadlmann J, Schahs M et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6(4), 392-402 (2008).
34. Sourrouille C, Marquet-Blouin E, D'Aoust MA et al. Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J. 6(7), 702-721 (2008).
35. Cox KM, Sterling JD, Regan JT et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotech. 24(12), 1591-1597 (2006).
36. Bakker H, Rouwendal GJ, Karnoup AS et al. An antibody produced in tobacco expressing a hybrid (31,4- galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl Acad. Sci. USA 103(20), 7577-7582 (2006).
37. Palacpac NQ, Yoshida S, Sakai H et al. Stable expression of human ( 1,4- galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl Acad. Sci. USA 96(8), 4692-4697 (1999).
38. Bakker H, Bardor M, Molthoff JW et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl Acad. Sci. USA 98(5), 2899-2904 (2001).
39. Strasser R, Castilho A, Stadlmann J et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous ( 1,4-galactosylated N-glycan profile. J. Biol. Chem. 284(31), 20479-20485 (2009).
40. Castilho A, Strasser R, Stadlmann J et al. In planta protein sialylation through over-expression of the respective mammalian pathway. J. Biol. Chem. 285(21), 15923-15930 (2010).
41. Rouwendal GJ, Florack DE, Hesselink T, Cordewener JH, Helsper JP, Bosch D. Synthesis of Lewis X epitopes on plant N-glycans. Carbohydr. Res. 344(12), 1487-1493 (2009).
42. Rouwendal GJ, Wuhrer M, Florack DE et al. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17(3), 334-344 (2007).
43. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1(2), 135-145 (2001).
44. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and langerhans cells. Nat. Rev. Immunol. 2(2), 77-84 (2002). (Pubitemid 37323231)
45. Geijtenbeek TBH, van Vliet SJ, Engering A, 't Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Ann. Rev. Immunol. 22(1), 33-54 (2004).
46. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-( . Nat. Immunol. 9(4), 361-368 (2008).
47. Burgdorf S, Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr. Opin. Immunol. 20(1), 89-95 (2008).
48. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Ann. Rev. Immunol. 20(1), 621-667 (2002).
49. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHC II pathway. Cell 117(5), 677-687 (2004).
50. Petrovsky N. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine 24(Suppl. 2), S26-S29 (2006).
51. Huang D-F, Tang Y-F, Nie S-P, Wan Y, Xie M-Y, Xie X-M. Effect of phenylethanoid glycosides and polysaccharides from the seed of Plantago asiatica L. on the maturation of murine bone marrow-derived dendritic cells. Eur. J. Pharmacol. 620(1-3), 105-111 (2009).
52. Sun H-X, Wang H, Xu H-s, Ni Y. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine 27(30), 3984-3991 (2009).
53. Kensil C, Patel U, Lennick M, Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146(2), 431-437 (1991).
54. Singh SK, Stephani J, Schaefer M et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol. Immunol. 47(2-3), 164-174 (2009).
55. Xie J, Guo L, Ruan Y et al. Laminarin- mediated targeting to dectin-1 enhances antigen-specific immune responses. Biochem. Biophys. Res. Comm. 391(1), 958-962 (2010).
56. Ahlers JD, Belyakov IM. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol. Med. 15(6), 263-274 (2009).
57. Shreffler WG, Castro RR, Kucuk ZY et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 177(6), 3677-3685 (2006).
58. Kolarich D, Altmann F. N-glycan analysis by matrix-assisted laser desorption/ ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen allergen Ole e 1. Anal. Biochem. 285(1), 64-75 (2000).
59. Koppel EA, Ludwig IS, Appelmelk BJ, van Kooyk Y, Geijtenbeek TB. Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1. Immunobiology 210(2-4), 195-201 (2005).
60. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kB. Immunity 26(5), 605-616 (2007).
61. Tacket CO. Plant-based oral vaccines: results of human trials. Curr. Top. Microbiol. Immunol. 332, 103-117 (2009).
62. Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7(10), 790-802 (2007).
63. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388(6640), 394-397 (1997).
64. Brown GD, Gordon S. A new receptor for (3-glucans. Nature 413(6851), 36-37 (2001).
65. Brooks SA. Strategies for analysis of the glycosylation of proteins: current status and future perspectives. Mol. Biotechnol. 43(1), 76-88 (2009).